Japan's Bushu Pharmaceuticals Ltd. has entered into a business alliance agreement with Suzuken Co., Ltd. to offer a se...
Japanese firm Daiichi Sankyo Company has entered into an exclusive licensing agreement with US based Esperion Therapeuti...
Ergomed plc, a company focused on providing specialised services to the pharmaceutical industry, announces that its Prim...
Japan based NEC Corporation announced a collaboration between NEC XON, the United Nations Human Settlements Programme (U...
The Oncidium Foundation, a non-profit organization created to promote and support the development of radiopharmaceutical...
FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...
Terumo Blood and Cell Technologies and CSL Plasma announced a collaboration to deliver a new plasma collection platform ...
ITOCHU Corporation announced on April 15, 2021, that it has made a decision to establish Hyuga Biomass Power G...
Japanese-European team of scientists, including researchers from Fujita Health University, describe mutations in the&n...
Japan's pioneering life science organizations seeking to navigate Japanese market entry gained a new pathway. Shonan Hea...
Researchers from The University of Tokyo have developed a novel device for the safe and effective long-term transplant...
US based BioCryst Pharmaceuticals, Inc. has announced that the Japanese National Health Insurance System (NHI) has appro...
Thermo Fisher Scientific Inc. has announced on April 12, 2021 that the U.S. Food and Drug Administration (FDA) has grant...
L Catterton, US based consumer-focused private equity firm, has announced an investment of JPY 20 billion into PHC ...
Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Jap...
Hitachi, Ltd. and Axcelead, Inc. have announced that they have agreed on a comprehensive collaborative partnership to de...
Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...
Leading Japanese medical VR company Jolly Good Inc. has recently established a specialized DTx Division to develop digit...
